XML 78 R135.htm IDEA: XBRL DOCUMENT v2.4.0.6
Parent Company Financial Statements (Statements of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities:      
Net income $ 35,074 $ 29,724 $ 24,051
Adjustments to reconcile net income to net cash provided by operating activities:      
(Increase) decrease in other assets (7,987) (2,804) 646
Net cash provided by operating activities 5,467 37,199 30,439
Net cash provided by (used in) investing activities 25,337 (158,576) 10,149
Cash flows from financing activities:      
Issuance of treasury stock, including net deferred compensation plan activity 0 0 44
Proceeds from the issuance of common stock under dividend reinvestment plan 0 754 1,002
Proceeds from the exercise of stock options and issuance of other compensation-related equity instruments 1,257 885 785
Tax benefit (expense) from stock option exercises and issuance of other compensation-related equity instruments 210 115 65
Cash dividends paid (15,133) (14,205) (13,582)
Net cash (used in) provided by financing activities (25,174) 115,661 (5,112)
Net increase (decrease) in cash and cash equivalents 5,630 (5,716) 35,476
Cash and cash equivalents at beginning of year 87,020 92,736 57,260
Cash and cash equivalents at end of year 92,650 87,020 92,736
Parent Company [Member]
     
Cash flows from operating activities:      
Net income 35,074 29,724 24,051
Adjustments to reconcile net income to net cash provided by operating activities:      
Equity in undistributed earnings of subsidiaries 20,177 16,557 10,190
(Increase) decrease in dividend receivable (298) (660) 360
(Increase) decrease in other assets 77 (246) (373)
Increase (decrease) in accrued expenses and other liabilities (215) 281 (92)
Other, net (237) (115) (109)
Net cash provided by operating activities 14,224 12,427 13,647
Net cash provided by (used in) investing activities 0 0 0
Cash flows from financing activities:      
Issuance of treasury stock, including net deferred compensation plan activity 0 0 44
Proceeds from the issuance of common stock under dividend reinvestment plan 0 754 1,002
Proceeds from the exercise of stock options and issuance of other compensation-related equity instruments 1,257 885 785
Tax benefit (expense) from stock option exercises and issuance of other compensation-related equity instruments 210 115 65
Cash dividends paid (15,133) (14,205) (13,582)
Net cash (used in) provided by financing activities (13,666) (12,451) (11,686)
Net increase (decrease) in cash and cash equivalents 558 (24) 1,961
Cash and cash equivalents at beginning of year 3,106 3,130 1,169
Cash and cash equivalents at end of year $ 3,664 $ 3,106 $ 3,130